Jefferies analyst Kelly Shi initiated coverage of BeiGene with a Buy rating and $287 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BGNE:
- BeiGene reports settlement and termination agreement with Bristol-Myers
- BeiGene reports Q2 EPS (28c), consensus ($2.81)
- BeiGene announces CHMP opinion recommending approval for tislelizumab
- BeiGene to hold an investor research and development day
- PepsiCo downgraded, Chewy upgraded: Wall Street’s top analyst calls